EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Artificial Intelligence for the Treatment and Management of Colorectal Liver Metastases

Kaitlyn M Weyman, Anai N Kothari

Clinics in Colon and Rectal Surgery · 2026-05 · 39 (03) · 235-241

DOI: 10.1055/a-2769-1413 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinics in Colon and Rectal Surgery, online erschienen am 29.12.2025. Verfasst von Kaitlyn M Weyman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin, United States. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is the third most commonly diagnosed malignancy worldwide. Prognosis is significantly worsened in patients with colorectal liver metastases (CRLM), whose management requires a multidisciplinary approach encompassing diagnosis, systemic therapy, surgery, and surveillance. Artificial intelligence (AI) offers the potential to improve treatment processes and outcomes across all aspects of CRLM care. This review summarizes current and future applications of AI throughout the CRLM treatment continuum. In diagnostics, radiomics-based AI models have demonstrated improved sensitivity in detecting small or ambiguous liver lesions, supporting radiologist interpretation, and improving efficiency. Similarly, AI models are increasingly employed to predict systemic treatment response, using deep learning (DL) to extract imaging-derived features that correlate with genomic and histopathologic profiles relevant to therapy selection. In surgical planning, AI tools can assist in preoperative preparation and optimization by measuring tumor volume and transection planes. Intraoperatively, computer vision and augmented reality are emerging to support tumor localization, margin assessment, and real-time anatomical navigation. Postoperatively, advanced AI models can integrate clinical, radiologic, and molecular data to stratify recurrence risk and inform individualized follow-up strategies. Despite its promise, clinical translation of AI in CRLM remains limited by the retrospective nature of many studies, challenges with external validation, and limitations in the interpretability of model decisions. Still, AI has the potential to be a transformative tool in the treatment of CRLM by supporting precision, standardization, and personalization across the treatment spectrum.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligencecolorectal cancerliver metastasesradiogenomicsradiomics

Autor:innen und Institutionen

  • Department of General Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.
  • Division of Surgical Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.

Zitieren

APA

Weyman, K. M., & Kothari, A. N. (2026). Artificial Intelligence for the Treatment and Management of Colorectal Liver Metastases. Clinics in Colon and Rectal Surgery, 39(03), 235-241. https://doi.org/10.1055/a-2769-1413

Vancouver

Weyman KM, Kothari AN. Artificial Intelligence for the Treatment and Management of Colorectal Liver Metastases. Clinics in Colon and Rectal Surgery. 2026;39(03):235-241. doi:10.1055/a-2769-1413

BibTeX
@article{Weyman2026,
  author = {Weyman, Kaitlyn M and Kothari, Anai N},
  title = {Artificial Intelligence for the Treatment and Management of Colorectal Liver Metastases},
  journal = {Clinics in Colon and Rectal Surgery},
  year = {2026},
  volume = {39},
  number = {03},
  pages = {235--241},
  doi = {10.1055/a-2769-1413}
}
Kostenlos starten →